Classification
Product TypeIngredient
Product FormPowder (enzyme preparation)
Industry PositionNutraceutical and Food-Processing Ingredient
Market
Bromelain is a proteolytic enzyme preparation derived from pineapple (Ananas comosus), commercialized globally as a dietary supplement ingredient and as a food-processing aid. In food applications, Codex GSFA lists bromelain (INS 1101(iii)) under GMP use provisions across multiple food categories, supporting cross-border formulations. Commercial trade is strongly quality- and assay-driven, with pharmacopeial definitions and activity-based specifications (e.g., USP Papain Units) shaping buyer requirements. Supply is structurally linked to pineapple cultivation and processing in tropical origins because pineapple stem is a primary source material for standardized bromelain preparations.
Risks
Regulatory Compliance HighBromelain frequently crosses regulatory boundaries as both a dietary supplement ingredient and a food-use enzyme/additive; non-compliance with GMP, identity/potency expectations, or permitted-use conditions can lead to shipment holds, recalls, or market-access loss. Codex GSFA permissions (INS 1101(iii), GMP) and dietary-supplement CGMP expectations (e.g., 21 CFR Part 111 in the United States) make documentation and specification control central to sustained trade.Contract to activity-based specifications (e.g., USP monograph assay units), maintain full traceability to pineapple stem source, and operate under applicable CGMP systems with documented identity/potency testing and change control.
Quality Variability MediumBromelain is a mixture of enzymes/proteins derived from plant material and is typically concentrated and only partially purified; potency can vary by source material and processing, and commercial products may include carriers. This variability increases the risk of batch-to-batch inconsistency and buyer disputes unless standardized to a defined activity basis.Use validated activity assays (e.g., USP Papain Units), set acceptance ranges tied to labeled activity, and require certificate-of-analysis parameters that reflect potency and carrier composition.
Allergenicity MediumHypersensitivity reactions (including rash/urticaria and rare anaphylaxis) have been reported with bromelain use, creating reputational and liability risk for supplement brands and increasing scrutiny of labeling, traceability, and adverse-event monitoring in importing markets.Implement allergen-risk assessment and post-market monitoring; ensure clear labeling and robust complaint handling aligned with dietary supplement quality systems.
FAQ
What is bromelain derived from?Bromelain is a proteolytic enzyme preparation derived from the pineapple plant (Ananas comosus), commonly sourced from the pineapple stem and also associated with the fruit.
How is bromelain potency specified in commerce?Bromelain is commonly standardized by enzyme activity rather than weight alone; the USP dietary supplement monograph specifies bromelain activity in USP Papain Units per mg with minimum activity requirements and tolerance around the labeled activity.
Is bromelain recognized for food-use applications in Codex standards?Yes. Codex GSFA lists bromelain as a food additive (INS 1101(iii)) with GMP-use provisions in specified food categories, meaning its use is permitted under Codex conditions when applied according to good manufacturing practice.